Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine Pretreatment to Reduce Etomidate-Induced Myoclonus
ChiCTR2500104733Phase 4Not yet recruiting
- Sponsor
- Changhai Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oliceridine in myoclonus, sponsored by Changhai Hospital. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
myoclonus
Beyond the preview
Go deeper on ChiCTR2500104733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104733.